LAVA Therapeutics NV

NASDAQ:LVTX   3:59:51 PM EDT
3.55
-0.09 (-2.47%)
Earnings Announcements

Lava Therapeutics Provides Business Update And Reports Q4 And Year End 2021 Financial Results

Published: 03/24/2022 10:40 GMT
LAVA Therapeutics NV (LVTX) - Lava Therapeutics Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial Results.
Lava Therapeutics - Qtrly Net Loss per Share, Basic and Diluted $0.38.
Lava Therapeutics NV - As of December 31, 2021, Lava Had Cash, Cash Equivalents and Investments Totaling $133.2 Million.
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.52

More details on our Analysts Page.